Blueprint Biomed is excited to announce its selection for the Medical Biotech Startup Program by Hello Tomorrow, in collaboration with BioLabs and the Digital Medical Hub.

Following a competitive selection process, the program officially kicked off last week. Over the coming weeks, Blueprint Biomed will participate in a tailor-made journey designed to refine its go-to-market strategy, engage with key opinion leaders (KOLs), and expand its network within the global medical biotech ecosystem.

The program bridges innovation hubs in Germany and France, leveraging the strengths of both countries’ biotech and healthcare communities. Earlier this month, the team took part in ecosystem tours in Berlin and Heidelberg, connecting with leading researchers, clinicians, and industry stakeholders in Germany. This week, attention turns to Paris, engaging with the vibrant French innovation landscape.

Paris agenda:

• March 10: Paris Ecosystem Tour

• March 11: BioLabs European Investor Day

• March 12: Hello Tomorrow Investor Day

• March 13–14: Global Summit & Demo Day

These events provide a unique platform to exchange ideas across borders, explore strategic partnerships, and strengthen Blueprint Biomed’s presence in both German and French markets. The team looks forward to connecting with fellow innovators, investors, and industry leaders, sharing its vision, and advancing its Medtech solution toward patients.